Frontiers in Molecular Biosciences (Aug 2024)

LncRNAs ILF3AS1, MMP3, and MMP9 as well as miRNA-212 as emerging novel biomarkers for childhood epilepsy

  • Amena Rezk Mohammed,
  • Wafaa Abdelaziz Emam,
  • Shaymaa A. Mohammed,
  • Alshaymaa A. Abd Elalim,
  • Eatemad Nabil Abdelhalim Mansour,
  • Haidy Mahmoud Nasr,
  • Aya A. Ghamry,
  • Sabah M. Alkhawagah,
  • Doaa Sadek Ahmed Fathy,
  • Rasha Sobhy Elattar,
  • Yasser Gaber Ibrahim Abish,
  • Abdullah Hussein,
  • Boshra Ahmed Zaghloul,
  • Marwa K. Khairallah,
  • Norah Alharbi,
  • Salwa Seif Eldin,
  • Amal Fahmy Dawood,
  • Marwa A. Sabet,
  • Marwa G. Gamea,
  • Suzan Eid Elshishtawy Ibrahim,
  • Aliaa A. Mosa,
  • Marwa A. Dahpy,
  • Marwa A. Dahpy

DOI
https://doi.org/10.3389/fmolb.2024.1434023
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundGlobally, approximately 70 million people suffer from epilepsy. Infants constitute a significant percentage of these cases. Hence, there is a significant need for better understanding of the pathophysiology of epilepsy through laboratory and radiological methods for early detection and optimized management. Interleukin enhancer binding factor 3 antisense RNA l (ILF3AS1) is a long non-coding RNA (lncRNA) that enhances the expressions of matrix metalloproteinase 3 (MMP3) and matrix metalloproteinase 9 (MMP9), which are considered to be epileptogenic.AimWe aimed to assess the serum expressions of the lncRNAs ILF3AS1, MMP3, and MMP9 along with microRNA-212 (miRNA-212) as predictive biomarkers in children with epilepsy; we also assessed their correlations with magnetic resonance imaging (MRI) findings.Subjects and MethodsFifty children with epilepsy and fifty healthy controls were considered in this study. Serum expressions of the lncRNA ILF3AS1 and miRNA-212 were estimated by quantitative real-time polymerase chain reaction (qPCR). Serum concentrations of MMP3 and MMP9 were estimated by enzyme-linked immunosorbent assay (ELISA) in parallel with MRI findings and different baseline biochemical parameters of all the subjects.ResultsThe results showed significantly higher levels of lncRNAs ILF3AS1, MMP3, and MMP9 as well as lower levels of miRNA-212 in children with epilepsy compared to the controls. The fold-change of miRNA-212 was a significant negative predictor (odds ratio = 0.153, p = 0.000). The receiver operating characteristic curves (Roc) showed that the areas under the curves for MMP3, MMP9, and lncRNA ILF3AS1 as well as the fold-change for miRNA-212 were 0.659, 0.738, 0.656, and 0.965, respectively. Brain lesions were detected in 15 patients (30%) with epilepsy, whereas the remaining 35 patients (70%) had normal results.ConclusionSerum levels of the lncRNA ILF3AS1 among children with epilepsy were higher than those in the control group and were associated with upregulation of both MMP3 and MMP9 as well as downregulation of miRNA-212 expressions, suggesting their predictive utility in monitoring the development of epilepsy; this also means that a treatment plan focusing on the ILF3AS1/miRNA-212/MMP3/MMP9 axis could be an effective strategy for treating epilepsy.

Keywords